Novavax vaccine

The federal government says it will continue its partnership with Novavax “at this time” despite the Maryland-based drugmaker’s worries it could go out of business within the year. Novavax executives told investors on a conference…

Novavax Inc.’s shares plunged 28 per cent in U.S. early trading on Wednesday, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business. The stock fell 28.3 per cent to a three-year low of US$6.64…

Covid-19 vaccine maker Novavax raised doubts Tuesday about its ability to continue its business, announcing plans to cut spending after struggles in rolling out its coronavirus jab. Shares of Novavax plummeted 25 percent in extended…

Novavax ends COVID vaccine sale agreement with Gavi. File | Photo Credit: Reuters Novavax Inc said on Monday it had delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of…

Novavax said it now expects 2022 total revenue in the range of $2 billion to $2.3 billion, compared with its prior forecast of $4 billion to $5 billion Novavax said it now expects 2022 total revenue in the range of $2 billion to $2.3…

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for…

The U.S. Food and Drug Administration has raised concerns about a possible risk of heart inflammation from Novavax Inc’s NVAX.OCOVID-19 vaccine, even as the company’s data showed it could reduce the chances of mild-to-severe disease.…

Novavax’s COVID-19 vaccine has been approved for use in adults aged 18 years of age and older in Canada. Health Canada updated the list of approved COVID-19 vaccines on Thursday to include Novavax’s product. Pfizer, Moderna,…

In an attempt to deliver our vaccine to those in India and across the globe amid rising concerns over new Covid-19 variant, the Drugs Controller General of India (DCGI) has issued emergency use authorization (EUA) for Covovax,…

An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India's COVID-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday.…